Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Breast Neoplasms 3Neoplasm, Residual 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Burkitt Lymphoma 2Wilms Tumor 1Subcutaneous panniculitis-like T-cell lymphoma 1Sarcoma 1Rhabdomyosarcoma 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Enteropathy-Associated T-Cell Lymphoma 1Carcinoma, Hepatocellular 1Body Weight 1

Interventions

Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Metformin 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Body Weight × Doxorubicin × Clear all
NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡